Project CBD

NOVEMBER 11, 2023

In general, I think that botanical medicine is safer than pharmaceutical medicine, that the chances of causing harm are much less. I include pharmaceutical drugs in that category. In general, I think that botanical medicine is safer than pharmaceutical medicine. They’re less interested in the pharmaceutical versions.

Medicine 308

Medicine Research and Development Pharmaceutical Cannabis 308

NORML

JANUARY 11, 2019

Legislation is pending, House Bill 1272, to expand access to medical cannabis in North Dakota. Legislation is pending, House Bill 350, to expand medical cannabis access. Legislation is pending, House Bill 335, to expand access to medical cannabis in New Hampshire. Click here to email your lawmakers in support of medical access.

Legislation 226

Legislation Decriminalization Hemp Patients 226

NORML

FEBRUARY 23, 2020

2227) is bipartisan legislation that removes marijuana from the Controlled Substances Act, thus decriminalizing the substance at the federal level and enabling states to set their own policies. Send a message to your lawmakers in support of medical marijuana access. AL resident? VA resident? West Virginia.

Legislation 253

Legislation Patients Decriminalization Access 253

NORML

FEBRUARY 8, 2019

Senator Ron Wyden introduced legislation in the Senate — The Marijuana Revenue and Regulation Act — to permit states to establish their own marijuana regulatory policies free from federal interference. Click here to email your lawmakers in support of medical cannabis access in school. A subcommittee of the U.S. FL resident?

Legislation 196

Legislation Decriminalization Patients Access 196

CannaTech

SEPTEMBER 23, 2019

The acceptance of medical cannabis by clinicians, researchers and government bodies is fairly universal, and patients have benefited from widespread access to full-spectrum cannabis in flower and oil form. Israel’s approach to cannabis has contributed to reducing stigma and increasing access for patients around the world.

Patients 79

Patients Policy Clinical Trials Research and Development 79

NORML

FEBRUARY 1, 2019

At the state level, activists in Florida and Missouri gathered in their state capitals along side state and local NORML chapters to lobby state lawmakers in favor of sensible marijuana policy reform. Click here to email your lawmakers in support of banking access. John Fetterman, Lt. CA resident? CT resident? Update : S. FL resident?

Legislation 189

Legislation Decriminalization Access Patients 189

The Cannigma

MARCH 25, 2021

A United Kingdom police chief proposed a novel idea this January: Allow drug-dependent inmates access to free cannabis to help them overcome opioid addiction. This creates a situation where state detention facilities — even where cannabis is legal — do not allow inmates access to medical cannabis because it violates federal law.

Marijuana 145

Marijuana Access Law Pharmaceutical 145

Project CBD

JULY 28, 2023

You need access to sophisticated analytical methods to discern product purity from the isomeric byproducts formed, which is why production from hemp-derived cannabinoid products needs to be done under the appropriate FDA regulations for API [active pharmaceutical ingredient] synthesis and manufacturing.

THC 219

THC Cannabinoids Hemp Research and Development 219

NORML

FEBRUARY 29, 2020

2227) is bipartisan legislation that removes marijuana from the Controlled Substances Act, thus decriminalizing the substance at the federal level and enabling states to set their own policies. Send a message to your lawmakers in support of access to edibles. Send a message to your lawmakers in opposition to arbitrary THC limits.

Legislation 165

Legislation Decriminalization Patients Edibles 165

Project CBD

FEBRUARY 28, 2023

5 In June 2018, the FDA approved Epidiolex® (GW Pharmaceuticals; Cambridge, UK), the first FDA-approved pharmaceutical drug to contain a “purified drug substance [CBD] derived from marijuana,” for the treatment of seizures associated with two rare epilepsy disorders. Accessed July 25, 2021. Accessed October 17, 2022.

CBD 144

CBD Seed-To-Sale Food Access 144

Cannabis Law Report

OCTOBER 26, 2019

The US subsidiary of GW Pharmaceuticals, behind the only FDA-approved cannabis extract-based medicine, is lobbying in all 50 states. GW is the world’s oldest and largest pharmaceutical company solely focused on producing medicines derived from cannabis plants, which it grows in Britain. By Nikitha Sattiraju.

Pharmaceutical 45

Pharmaceutical Research and Development Banking Therapy 45

Cannabis Law Report

NOVEMBER 23, 2021

Department of Veterans Affairs (VA) says that while current federal marijuana laws have prevented the department’s physicians from recommending medical cannabis to military veterans, officials are “looking at” the possibility of an internal policy change and have discussed it with the White House. And it was very profound,” McDonough said.

Policy 52

Policy Marijuana Pharmaceutical Treatment 52

NORML

JANUARY 25, 2019

At the state level this week, activists gathered in Denver in conjunction with Colorado and Denver NORML chapters to lobby their state lawmakers in favor of workplace drug testing reforms, social consumption, parental protections and expanding access to the state’s medical cannabis program. HI resident? IA resident? MO resident?

Legislation 187

Legislation Patients Hemp Oil 187

Cannabis Law Report

JUNE 1, 2022

This acquisition will accelerate Khiron’s growth in Europe by controlling the complete value chain for its products and gaining direct access to German pharmacies. Pharmadrug GmbH has been active worldwide for almost 40 years as a manufacturer and wholesaler of medicinal products and active pharmaceutical ingredients.

Pharmaceutical 52

Pharmaceutical Medicine Extraction Cannabinoids 52

MJ Business Attorneys

JUNE 29, 2018

So for now, we wait in anticipation for the DEA to commence proceedings to determine how to amend the scheduling of CBD under the CSA in a way that will allow for Epidiolex to be prescribed by health care providers and dispensed by pharmaceutical companies appropriately and legally.

DEA 113

DEA CBD Pharmaceutical Research and Development 113

Cannabis Law Report

JULY 1, 2021

The Petrie-Flom Center for Health Law Policy, Biotechnology, and Bioethics at Harvard Law School is engaged in a three-year initiative to examine the ethical, legal, and social implications of psychedelics research, commerce, and therapeutics. Access to Psychedelic Therapies and Equity in Emerging Psychedelics Industries. Background.

Law 59

Law Policy Research and Development Clinical Trials 59

Cannabis Law Report

JUNE 28, 2021

His blend of medical, governmental, and healthcare policy experience makes him well positioned to support Kanabo’s mission to establish and lead a regulated medicinal cannabis market in the UK and Europe. As such, the company is creating a new standard in the industry by providing better and safer access to such cannabis medications.

Research and Development 105

Research and Development Chronic Pain Medicine Policy 105

The Cannigma

JUNE 1, 2021

Marijuana is not legal in France, and the country is seen as having some of the strictest cannabis policies in western Europe. Patients can take part if they have a medical condition which has not responded to pharmaceutical drugs. Some 170 hospitals will participate in the two-year experiment. Who can get medical cannabis in France?

Law 119

Law Epilepsy Programs Patients 119

Canna Law Blog

MARCH 4, 2020

People are increasingly using ketamine for ailments that resist treatment through traditional pharmaceutical drugs. “ Off-label use ” (which is extremely common) is: the use of pharmaceutical drugs for an unapproved indication or in an unapproved age group, dosage, or route of administration.

Therapy 118

Therapy Legalization Chronic Pain DEA 118

Veriheal

JUNE 20, 2022

.” The LPP’s mission is: “Through intervention, advocacy, and awareness campaigns the Last Prisoner Project works to redress the past and continuing harms of these unjust laws and policies.” The FDA has also approved a few cannabis-based pharmaceutical drugs. According to the U.S.

Chronic Pain 97

Chronic Pain Advocacy Pharmaceutical Legalization 97

Cannabis Law Report

JULY 1, 2021

The Project on Psychedelics Law and Regulation at the Petrie-Flom Center for Health Law Policy, Biotechnology, and Bioethics at Harvard Law School will advance evidence-based psychedelics law and policy. Mason Marks: The project’s goal is to promote safety, innovation, equity, and accessibility in emerging psychedelics industries.

Law 81

Law Research and Development Therapy DEA 81

Sensi Seeds

JANUARY 4, 2019

Since 2001, Canadians seeking to use cannabis for medical treatment have had access to it under the Marihuana Medical Access Regulations (MMAR ). It allows patients to have access to medicinal cannabis without danger of being criminalized. Context of the Medicinal Cannabis Situation.

Medicine 75

Medicine Research and Development Patients Programs 75

Cannabis Law Report

JANUARY 10, 2020

Schlag has a keen interest in national and international drug policies, related regulatory challenges and public communications. Serving on a number of for-profit and non-profit boards, Anand is, most notably, on the boards of the Centre for Medicinal Cannabis in the UK and Canadians for Fair Access to Medical Marijuana (CFAMM).

Research and Development 59

Research and Development Supply Chain Pharmaceutical Medicine 59

Cannabis Law Report

JULY 26, 2021

From recreational to pharmaceutical applications, we see amazing potential for novel applications of the device.”. NEITHER THE CSE NOR ITS MARKET REGULATOR (AS THAT TERM IS DEFINED IN THE POLICIES OF THE CSE) ACCEPTS RESPONSIBILITY FOR THE ADEQUACY OR ACCURACY OF THIS RELEASE.

Events 105

Events Cannabinoids Advocacy Cannabis 105

Veriheal

SEPTEMBER 7, 2022

’s medical cannabis program come on the heels of a previously enacted emergency amendment focused on senior citizens: The Medical Marijuana Patient Access Extension Emergency Amendment Act of 2022 allowed D.C. The State of Patients’ Rights and Access in America Today. These changes to D.C.’s

Patients 98

Patients Programs Access Treatment 98

Cannabis Law Report

JULY 21, 2022

COMPASS Pathways plc (Nasdaq: CMPS) (“COMPASS”), a mental health care company dedicated to accelerating patient access to evidence-based innovation in mental health, today announced that it has appointed Kabir Nath as Chief Executive Officer, effective August 1, 2022. London, UK July 19, 2022.

Therapy 52

Therapy Research and Development Pharmaceutical Patients 52

Veriheal

SEPTEMBER 22, 2021

We’re encouraged that SB711 has been advanced by the Judiciary Committee,” said DeVaughn Ward , who serves as senior legislative counsel for the Marijuana Policy Project. The final stage would see the governor put his signature on North Carolina’s medical cannabis bill. Home cannabis cultivation, on the other hand, would be forbidden.

Legalization 124

Legalization Patients Cultivation Legislation 124

Canna Law Blog

MARCH 2, 2019

.” Gottleib qualified this by saying that CBD access is not a straightforward issue because CBD has already been investigated and approved as a drug, Epiodiolex , which generally means CBD cannot be added to food. This is where things get interesting.

Hemp 107

Hemp CBD Programs Food 107

Cannabis Law Report

APRIL 21, 2022

Commercialization & Patient Access · Any City, Any State, California. We are a diverse team that shares a deep belief in the critical need for innovation and expanded access in the treatment of mental health conditions. MAPS PBC strives to establish a supportive, equitable and accessible work environment. Executive Summary.

Advocacy 52

Advocacy Therapy Clinical Trials Treatment 52

NORML

JANUARY 2, 2019

Dan Viets says it will still be until next year for people to access cannabis. If legislation is introduced that does not address our policy concerns, Chicago NORML, its supporters and community partners are prepared to push back until we are satisfied that every opportunity for advancement has been exhausted,”. Read more from KOMU !

Advocacy 128

Advocacy Decriminalization Legislation Cultivation 128

Cannabis Law Report

JANUARY 16, 2020

The European Medicinal Cannabis Association (EUMCA), the newly formed Brussels-based industry body which advocates for European evidence-based policy to improve patient access to high-quality cannabis treatment, has announced the appointment of Professor Jones, CBE, FMedSci, as its new Chairman. Professor Jones.

Medicine 45

Medicine Research and Development Pharmaceutical Policy 45

Cannabis Law Report

JUNE 26, 2019

In May 2019, Florida Commissioner of Agriculture Nikki Fried announced that a newly-created and appointed Medical Marijuana Advisory Committee of 18 doctors, lawyers, patients, industry leaders, and advocates will be implemented in order to “advance and modernize policies” to move Florida into the future of medical marijuana.

Marijuana 65

Marijuana Agriculture Research and Development Education 65

CannaTech

AUGUST 9, 2018

It wasn’t until the second time that I tried CBD, that I forgot to take my usual pharmaceutical anti-epileptic medication. Unlike me, she is based in the UK, and therefore we still don’t have access to medical cannabis for her. But the main push stems from our fight to gain access to this medicine for my sister Tamsin.

Strains 69

Strains Epilepsy Advocacy Medicine 69

MMJ Recs

MARCH 23, 2024

Legalization may offer expanded access to medical cannabis for patients suffering from various conditions, providing alternative treatment options and symptom relief. However, challenges remain in ensuring equitable access to participation in the legal cannabis market and addressing disparities in ownership and representation.

Legalization 52

Legalization Access Programs Education 52

Cannabis Law Report

MARCH 29, 2022

to acquire Dutch medical cannabis company APIRx Pharmaceutical BV. On the other hand, the international marketplace is far more focused on true medicinal, pharmaceutical development, infrastructure, data, formulations, and the continued development thereof. The next day, on March 24 th , Australia’s Incannex Healthcare paid $93.3M

Pharmaceutical 52

Pharmaceutical Cannabinoids Data Policy 52

Cannabis Law Report

JUNE 16, 2021

TruTrace Technologies is the developer of fully-integrated software, secured on a blockchain infrastructure, that gives clients’ the ability to store, manage, share and immediately access quality assurance and testing details, COAs, as well as motion and movement intelligence on inventory. Corey Herscu for TruTrace Technologies.

Events 74

Events Access Legislation Conditions 74

Cannabis Law Report

JUNE 9, 2021

MAPS is committed to bringing these healing modalities to the world and providing them in such a way that communities that most need mental health resources have access to them. MAPS strives to continually improve upon the supportive, equitable, and accessible work environment. Pharmaceutical or cannabis industry experience a plus.

Research and Development 58

Research and Development Compliance Compliance Education 58